Neuroprotective therapy in Parkinson disease

Sheng Chen, Weidong Le

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations


During the past decade, there has been a remarkable progress in our understanding of the biology of Parkinson disease (PD), which has been translated into searching for novel therapy for PD. Much focus is shifted from the development of drugs that only relieve PD symptoms to new generation of remedies that can potentially protect dopaminergic neurons and modify the disease course. Several novel therapeutic approaches have been tested in preclinical experiments and in clinical trials, including molecules targeting on genes involved in the pathogenesis of the disease, neurotrophic factors critical for dopaminergic neuron survival and function, new generation of dopamine receptor agonists that may possess neuroprotective effects, and agents of antioxidation, antiinflammation, and antiapoptosis. The results of these studies will shed new light to our hope that PD can be cured in the future.

Original languageEnglish (US)
Pages (from-to)445-457
Number of pages13
JournalAmerican journal of therapeutics
Issue number5
StatePublished - Sep 2006


  • Antiapoptosis
  • Antiinflammation
  • Dopamine receptor agonist
  • Gene therapy
  • Neuroprotection
  • Neurotrophic factor
  • Parkinson disease
  • Radical scavenge

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Neuroprotective therapy in Parkinson disease'. Together they form a unique fingerprint.

Cite this